Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 7
2007 5
2008 9
2009 2
2010 12
2011 11
2012 15
2013 9
2014 14
2015 10
2016 7
2017 9
2018 12
2019 9
2020 9
2021 13
2022 4
2023 3
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Update on MRI in Evaluation and Treatment of Endometrial Cancer.
Maheshwari E, Nougaret S, Stein EB, Rauch GM, Hwang KP, Stafford RJ, Klopp AH, Soliman PT, Maturen KE, Rockall AG, Lee SI, Sadowski EA, Venkatesan AM. Maheshwari E, et al. Among authors: soliman pt. Radiographics. 2022 Nov-Dec;42(7):2112-2130. doi: 10.1148/rg.220070. Epub 2022 Aug 26. Radiographics. 2022. PMID: 36018785 Review.
Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.
Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q, Ring K, Munsell MF, Gershenson DM, Lu KH, Coleman RL. Slomovitz BM, et al. Among authors: soliman pt. J Clin Oncol. 2015 Mar 10;33(8):930-6. doi: 10.1200/JCO.2014.58.3401. Epub 2015 Jan 26. J Clin Oncol. 2015. PMID: 25624430 Free PMC article. Clinical Trial.
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.
Westin SN, Labrie M, Litton JK, Blucher A, Fang Y, Vellano CP, Marszalek JR, Feng N, Ma X, Creason A, Fellman B, Yuan Y, Lee S, Kim TB, Liu J, Chelariu-Raicu A, Chen TH, Kabil N, Soliman PT, Frumovitz M, Schmeler KM, Jazaeri A, Lu KH, Murthy R, Meyer LA, Sun CC, Sood AK, Coleman RL, Mills GB. Westin SN, et al. Among authors: soliman pt. Clin Cancer Res. 2021 Dec 1;27(23):6354-6365. doi: 10.1158/1078-0432.CCR-21-1656. Epub 2021 Sep 13. Clin Cancer Res. 2021. PMID: 34518313 Free PMC article. Clinical Trial.
Isolated vaginal recurrence in women with stage I endometrial cancer.
Rios-Doria E, Cun HT, Filippova OT, Mueller JJ, Alektiar KM, Ellenson LH, Makker V, Lakhman Y, Leitao MM Jr, Jhingran A, Soliman PT, Abu-Rustum NR. Rios-Doria E, et al. Among authors: soliman pt. Gynecol Oncol. 2023 Dec;179:9-15. doi: 10.1016/j.ygyno.2023.10.011. Epub 2023 Oct 20. Gynecol Oncol. 2023. PMID: 37864854
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice.
Jazaeri A, Coleman RL, Sood AK, Frumovitz MM, Soliman PT, Shafer A, Cutrera JJ, Klinger M, Sharafi SE, Johnson CAL, Villanueva VF, Hinchcliff EM, Dickens A, Cain KE, Anderson JE, Lu KH, Westin SN. Jazaeri A, et al. Among authors: soliman pt. Gynecol Oncol. 2018 Nov;151(2):374-380. doi: 10.1016/j.ygyno.2018.08.037. Epub 2018 Sep 10. Gynecol Oncol. 2018. PMID: 30213435 Free PMC article. Review.
Clinical and genomic landscape of RAS mutations in gynecologic cancers.
Son J, Zhang Y, Lin H, Mirallas O, Alvarez Ballesteros P, Nardo M, Clark N, Hillman RT, Campbell E, Holla V, Johnson AM, Biter AB, Yuan Y, Cobb LP, Gershenson DM, Jazaeri AA, Lu KH, Soliman PT, Westin SN, Euscher ED, Lawson BC, Yang RK, Meric-Bernstam F, Hong DS. Son J, et al. Among authors: soliman pt. Clin Cancer Res. 2024 Apr 30. doi: 10.1158/1078-0432.CCR-23-2819. Online ahead of print. Clin Cancer Res. 2024. PMID: 38687597
143 results